Literature DB >> 6871065

The characteristics of [3H]-ouabain binding to human lymphocytes.

K E Pedersen, N A Klitgaard.   

Abstract

The kinetic characteristics of [3H]-ouabain binding to human lymphocytes and mixtures of mononucleated cells, and the maximum [3H]-ouabain binding capacities of these cells were studied. The [3H]-ouabain binding was compatible with a single class of receptors with a high affinity for the drug. No signs of positive or negative cooperativity could be demonstrated. In six experiments with pure lymphocyte preparations, the association and dissociation rate constants were 3.08 +/- 0.34 X 10(4)/M/S and 1.58 +/- 0.50 X 10(-4)/S. The dissociation constant derived from equilibrium studies on lymphocytes was 0.68 +/- 0.21 X 10(-8) M, which was identical to that of mononucleated cells. In healthy subjects the maximum [3H]-ouabain binding capacities, which reflect the number of sodium/potassium pump sites were 43154 +/- 8037 molecules/cell (n = 25) in lymphocytes and 75474 +/- 6764 (n = 9) molecules/cell in mixtures of mononucleated cells. Direct determination of the [3H]-ouabain binding capacity of lymphocytes can be performed with acceptable accuracy and precision using 30 ml whole blood. Provided high cell purity, this method may be useful, when studying sodium/potassium pump function in clinical settings.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6871065      PMCID: PMC1427934          DOI: 10.1111/j.1365-2125.1983.tb01546.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  22 in total

1.  The sodium pump.

Authors:  I M Glynn; S J Karlish
Journal:  Annu Rev Physiol       Date:  1975       Impact factor: 19.318

2.  The sodium-potassium adenosine triphosphatase: pharmacological, physiological and biochemical aspects.

Authors:  A Schwartz; G E Lindenmayer; J C Allen
Journal:  Pharmacol Rev       Date:  1975-03       Impact factor: 25.468

3.  Purification and characterization of (Na+ plus K+ )-ATPase. IV. Estimation of the purity and of the molecular weight and polypeptide content per enzyme unit in preparations from the outer medulla of rabbit kidney.

Authors:  P L Jorgensen
Journal:  Biochim Biophys Acta       Date:  1974-07-12

4.  Binding of the cardiac glycoside ouabain to intact cells.

Authors:  P F Baker; J S Willis
Journal:  J Physiol       Date:  1972-07       Impact factor: 5.182

5.  Mutual exclusion of ATP, ADP and g-strophanthin binding to NaK-ATPase.

Authors:  O Hansen; J Jensen; J G Norby
Journal:  Nat New Biol       Date:  1971-11-24

6.  Effect of monovalent cations on the ouabain iniibition of the sodium and potassium ion activated adenosine triphosphatase.

Authors:  R E Barnett
Journal:  Biochemistry       Date:  1970-11-24       Impact factor: 3.162

7.  Uptake of ( 3 H)ouabain and Na pump turnover rates in cells cultured in ouabain.

Authors:  L J Boardman; J F Lamb; D McCall
Journal:  J Physiol       Date:  1972-09       Impact factor: 5.182

8.  Quantitative aspects of ouabain binding to human erythrocyte and cardiac membranes.

Authors:  E Erdmann; W Hasse
Journal:  J Physiol       Date:  1975-10       Impact factor: 5.182

9.  Effects of digoxin-specific antibodies on accumulation and binding of digoxin by human erythrocytes.

Authors:  J D Gardner; D R Kilno; T J Swartz; V P Butler
Journal:  J Clin Invest       Date:  1973-08       Impact factor: 14.808

10.  The effects of sodium and potassium on ouabain binding by human erythrocytes.

Authors:  J D Gardner; T P Conlon
Journal:  J Gen Physiol       Date:  1972-11       Impact factor: 4.086

View more
  4 in total

1.  Measurement of specific [3H]-ouabain binding to different types of human leucocytes.

Authors:  N A Boon; V M Oh; E A Taylor; T Johansen; J K Aronson; D G Grahame-Smith
Journal:  Br J Clin Pharmacol       Date:  1984-08       Impact factor: 4.335

2.  3H-Ouabain binding to human mononuclear leucocytes.

Authors:  K Ludwig; L Brown; E Erdmann
Journal:  Klin Wochenschr       Date:  1985-10-15

3.  Ouabain inhibition of the sodium-potassium pump: estimation of ED50 in different types of human leucocytes in vitro.

Authors:  B Møller; A Vaag; T Johansen
Journal:  Br J Clin Pharmacol       Date:  1990-01       Impact factor: 4.335

4.  Angiotensin-converting enzyme inhibition as a therapeutic principle in Bartter's syndrome.

Authors:  P Jest; K E Pedersen; N A Klitgaard; N Thomsen; K Kjaer; E Simonsen
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.